Search

Edward H Liao

from Petaluma, CA
Get Report
Related to:
Jing Chun Liao, 57Jackey LiaoMoon Joo Lee, 53
Connected to:
Allen H Liao, 70Benedict S Liao, 85Celina S Liao, 30Chong Liao, 80Christy Liao, 38Chunyuan Liao, 48Danny J Liao, 45Edward R Liao, 51Elena T Liao, 42Elyse A Liao, 42

Edward Liao Phones & Addresses

  • Petaluma, CA

Work

Company: Law Office of Edward Liao, P.C. Address:

Specialities

Negligence • Personal Injury Litigation

Professional Records

Lawyers & Attorneys

Edward Liao Photo 1

Edward Liao - Lawyer

View page
Office:
Law Office of Edward Liao, P.C.
Specialties:
Negligence
Personal Injury Litigation
ISLN:
910624198
Admitted:
1994
University:
State University of New York at Stony Brook, B.A., 1990
Law School:
Benjamin N. Cardozo School of Law, J.D., 1993

Medicine Doctors

Edward Liao Photo 2

Edward R. Liao

View page
Specialties:
Pediatrics
Work:
Queens Care Health Centers
4618 Fountain Ave STE 102, Los Angeles, CA 90029
(323) 953-7170 (phone), (323) 663-2379 (fax)

Queenscare Health Center
4816 E 3 St, Los Angeles, CA 90022
(323) 780-4510 (phone), (323) 981-1662 (fax)
Education:
Medical School
University of Southern California Keck School of Medicine
Graduated: 2000
Conditions:
Acute Conjunctivitis
Allergic Rhinitis
Anemia
Bronchial Asthma
Chronic Sinusitis
Languages:
English
Description:
Dr. Liao graduated from the University of Southern California Keck School of Medicine in 2000. He works in Los Angeles, CA and 1 other location and specializes in Pediatrics. Dr. Liao is affiliated with Hollywood Presbyterian Medical Center.

Publications

Us Patents

Method For Identifying Variants In Gene Products From Gene Constructs Used In Cell Therapy Applications

View page
US Patent:
20230103457, Apr 6, 2023
Filed:
Jun 29, 2022
Appl. No.:
17/853708
Inventors:
- Santa Monica CA, US
Eugene Bolotin - Berkeley CA, US
Alexander S. Falk - Thousand Oaks CA, US
Edward H. Liao - Petaluma CA, US
International Classification:
G16B 20/20
C12Q 1/6869
Abstract:
A method for ensuring that gene products used in cell therapy do not carry a risk of reduced efficacy or toxicity due to production of unintended variants. The method includes performing an in-silico analysis on the gene construct to identify and alter sequences likely to cause variants. Also, the method includes performing an in-vivo analysis consisting of RNA-sequence of construct based products. Variant detection may then be performed based on gapped reads from the RNA-sequence to determine variant expression levels, variant significance. The method may include repeating the in-silico analysis if identified variants are unacceptable.

Chimeric Antigen Receptor

View page
US Patent:
20230013874, Jan 19, 2023
Filed:
May 23, 2022
Appl. No.:
17/751266
Inventors:
- Santa Monica CA, US
Jodi Murakami - Culver City CA, US
Samuel T. Haile - Castro Valley CA, US
Edward H. Liao - Petaluma CA, US
International Classification:
A61K 35/17
C07K 14/725
A61P 35/00
C12N 15/85
C12N 5/0783
Abstract:
Provided are chimeric antigen receptors (CARs) comprising an NGK2D ecto domain. Provided are compositions, cells and cell therapies comprising the same. Further provided are methods of treatment.
Control profile
Edward H Liao from Petaluma, CA Get Report